Get the Stockscreener App
186.58
1.76%
-3.35
Icon Plc stock is traded at $186.58, with a volume of 700.27K.
It is down -1.76% in the last 24 hours and up +14.17% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$189.93
Open:
$188.44
24h Volume:
700.27K
Relative Volume:
0.72
Market Cap:
$14.25B
Revenue:
$8.19B
Net Income/Loss:
$758.19M
P/E Ratio:
20.32
EPS:
9.18
Net Cash Flow:
$1.06B
1W Performance:
+0.38%
1M Performance:
+14.17%
6M Performance:
+26.85%
1Y Performance:
-11.49%
1-Day Range:
$185.81
$191.85
1-Week Range:
$178.80
$191.85
52-Week Range:
$125.10
$228.28
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
186.58 | 14.50B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
Icon Plc $ICLR Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Bamco Inc. NY Lowers Position in Icon Plc $ICLR - MarketBeat
Boone Capital Management LLC Invests $13.94 Million in Icon Plc $ICLR - MarketBeat
Sei Investments Co. Acquires 309,635 Shares of Icon Plc $ICLR - MarketBeat
300,000 Shares in Icon Plc $ICLR Purchased by Camber Capital Management LP - MarketBeat
California Public Employees Retirement System Has $22.55 Million Stock Position in Icon Plc $ICLR - MarketBeat
Axa S.A. Cuts Stock Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Bought by Qube Research & Technologies Ltd - MarketBeat
Amundi Sells 7,228 Shares of Icon Plc $ICLR - MarketBeat
ICON plc Releases Findings from Two Biotech Sector Survey - marketscreener.com
Here’s How ICON plc (ICLR) Recovered from Challenges - Insider Monkey
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive - Business Wire
Icon Plc $ICLR Shares Sold by M&T Bank Corp - MarketBeat
Fayez Sarofim & Co Has $13.72 Million Holdings in Icon Plc $ICLR - MarketBeat
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛
Kennedy Capital Management LLC Sells 10,424 Shares of Icon Plc $ICLR - MarketBeat
Brant Point Investment Management LLC Sells 7,000 Shares of Icon Plc $ICLR - MarketBeat
Brown Advisory Inc. Buys 17,717 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Jump Financial LLC - MarketBeat
Invesco Ltd. Increases Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Quantbot Technologies LP - MarketBeat
BMO Capital reiterates Market Perform rating on ICON stock with $175 target - Investing.com UK
What ICON (ICLR)'s Trial Site Bottleneck Survey Reveals About Its Evolving CRO Partnership Strategy - simplywall.st
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup - Applied Clinical Trials
14,202 Shares in Icon Plc $ICLR Bought by Taikang Asset Management Hong Kong Co Ltd - MarketBeat
1,090,679 Shares in Icon Plc $ICLR Purchased by Norges Bank - MarketBeat
Distillate Capital Partners LLC Sells 10,245 Shares of Icon Plc $ICLR - MarketBeat
Brandes Investment Partners LP Purchases Shares of 207,533 Icon Plc $ICLR - MarketBeat
1832 Asset Management L.P. Boosts Stock Position in Icon Plc $ICLR - MarketBeat
Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - MSN
Free cash flow per share of ICON Plc – TRADEGATE:IJF - TradingView
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Si - PharmiWeb.com
Icon plc Announces Results of Its Latest Industry Survey - marketscreener.com
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions - Business Wire
River Road Asset Management LLC Invests $30.41 Million in Icon Plc $ICLR - MarketBeat
Icon Energy Corp. (ICON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Legacy Capital Wealth Partners LLC Acquires 2,296 Shares of Icon Plc $ICLR - MarketBeat
Russell Investments Group Ltd. Buys 18,198 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Grandeur Peak Global Advisors LLC - MarketBeat
Cetera Investment Advisers Has $2.03 Million Position in Icon Plc $ICLR - MarketBeat
Icon (ICLR) Net Margin % : 0.12% (As of Sep. 2025) - GuruFocus
Icon (ICLR) Common Stock : $6 Mil (As of Sep. 2025) - GuruFocus
Neuberger Berman Group LLC Has $30.29 Million Stock Position in Icon Plc $ICLR - MarketBeat
Quadrature Capital Ltd Has $5.14 Million Stock Position in Icon Plc $ICLR - MarketBeat
Boston Partners Sells 548,381 Shares of Icon Plc $ICLR - MarketBeat
JPMorgan Chase & Co. Decreases Stake in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Legal & General Group Plc - MarketBeat
American Century Companies Inc. Acquires 53,458 Shares of Icon Plc $ICLR - MarketBeat
Icon Is Hiring Project Manager – Apply Now for Life Science Jobs - BioTecNika
Thornburg Investment Management Inc. Has $10.86 Million Stock Position in Icon Plc $ICLR - MarketBeat
Should You Reconsider ICON After Its 15.6% Weekly Surge and Regulatory Headlines? - Sahm
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):